Hepsera

DRUG3 trials

Sponsors

Gilead Sciences, University of Washington

Conditions

Hepatitis B

Phase 4

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

CompletedNCT00230477

University of WashingtonHepatitis B

Start: 2003-04-30End: 2007-08-31Updated: 2007-11-15

Unknown Phase

Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

CompletedNCT00158717

Gilead SciencesHepatitis B

Start: 2003-04-30End: 2006-04-30Updated: 2014-01-07

Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.

TerminatedNCT00158704

Gilead SciencesHepatitis B

Start: 2002-01-31End: 2005-01-31Target: 400Updated: 2007-03-08